Reportedly, 50% of ES primary tumors express activated/phosphorylated STAT3 [44, 45] and germline mutations of Protein tyrosine phosphatase delta (PTPRD, a STAT3 phosphatase) have recently been described in three ES patients [46]. The gene discussed is PTPRD; the disease is Ewing sarcoma.